Evidence map›Paper›PMID 34398970›Full record

ArticleCancer2021

Post-traumatic stress symptomatology and adjustment of medical oncology practice during the COVID-19 pandemic among adult patients with cancer in a day care hospital.

Florence Joly, Olivier Rigal, Lydia Guittet, Sophie Lefèvre-Arbogast, Jean-Michel Grellard, Giulia Binarelli, Marie Lange, Chantal Rieux, Marie Fernette, Laure Tron and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Perceived health-related quality of life in people living with HIV co-infected with SARS-CoV-2 in France.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Florence JolyMedical Oncology Department, Francois Baclesse Center, Caen, France.
Olivier RigalMedical Oncology, Henri Becquerel Center, Rouen, France.
Lydia GuittetAnticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.
Sophie Lefèvre-ArbogastAnticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.ORCID 0000-0002-7857-6697
Jean-Michel GrellardClinical Research, Francois Baclesse Center, Caen, France.
Giulia BinarelliAnticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.
Marie LangeAnticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.ORCID 0000-0002-1749-2713
Chantal RieuxClinical Research, Francois Baclesse Center, Caen, France.
Marie FernetteClinical Research, Francois Baclesse Center, Caen, France.
Laure TronAnticipe (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), INSERM Unit 1086, Caen, France.
François GernierClinical Research, Francois Baclesse Center, Caen, France.
Romain TraversNorthWest Data Center, Caen, France.
Adeline MorelMedical Oncology Department, Francois Baclesse Center, Caen, France.
Doriane RichardClinical Research, Henri Becquerel Center, Rouen, France.
Bénédicte GriffonClinical Research, Francois Baclesse Center, Caen, France.
Alexandra LeconteClinical Research, Francois Baclesse Center, Caen, France.
Etienne BastienMedical Oncology Department, Francois Baclesse Center, Caen, France.
Florian QuilanMedical Oncology Department, Francois Baclesse Center, Caen, France.
Louis-Ferdinand PépinClinical Research, Henri Becquerel Center, Rouen, France.
Fabrice JardinClinical Research, Henri Becquerel Center, Rouen, France.
Marianne LeheurteurMedical Oncology, Henri Becquerel Center, Rouen, France.
Bénédicte ClarisseClinical Research, Francois Baclesse Center, Caen, France.
Justine LequesneClinical Research, Francois Baclesse Center, Caen, France.
Audrey FaveyrialMedical Oncology Department, Francois Baclesse Center, Caen, France.
Centre François Baclesse · LUInserm · FRLaboratoire National Henri Becquerel · FRDATA4 (France) · FR

Funding

Fondation ARC COVID202001320GEFLUC Normandie ("Les entreprises contre le cancer/Compagnies against cancer Rouen-Normandie)
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic may induce post-traumatic stress disorder (PTSD) symptoms among patients with cancer, who also face adaptations to their treatment. The authors assessed the occurrence of PTSD symptoms, investigated pandemic-induced adjustments in medical oncology practice in patients with cancer, and explored risk factors for PTSD and the association between PTSD symptoms, insomnia, and quality of life (QoL).

methodsThis prospective French study was conducted in patients with solid/hematologic tumors who were receiving medical treatment in the day care departments of 2 cancer centers during the lockdown. Adjustments to medical oncology practice were collected from medical records. PTSD (measured using the Impact of Event Scale-Revised), insomnia (measured using the Insomnia Severity Index), QoL (measured using the Functional Assessment of Cancer Therapy-General instrument), and cognitive complaints (measured using the Functional Assessment of Cancer Therapy-Cognitive Function instrument) were collected through validated questionnaires.

resultsClinical data and questionnaires were available for 734 and 576 patients, respectively. The median patient age was 64 years, and 69% of patients were women. Twenty-one percent of patients had PTSD. Twenty-seven percent (95% CI, 23%-30%) had an adjustment in their medical oncology program, including adjournments (29%), treatment interruptions (16%), modified treatment plans (27%), or adapted monitoring (27%). Women and patients experiencing an adjustment in oncology practice had a higher odds of PTSD (odds ratio= 2.10 [95% CI, 1.07-4.14] and 1.65 [95% CI, 1.03-2.63]; P < .05). PTSD symptoms were correlated with worse scores for QoL, cognition, and insomnia.

conclusionsTwenty-one percent of patients with cancer experienced PTSD symptoms associated with poor QoL during the first COVID-19-induced lockdown. Medical oncology practice was adjusted in approximately one-quarter of patients and was associated with the occurrence of PTSD symptoms. Psychosocial support should be offered in cancer centers to promote emotional resilience and avoid PTSD symptoms in patients.

Indexed as

COVID-19Day Care, MedicalNeoplasmsSleep Initiation and Maintenance DisordersStress Disorders, Post-TraumaticAdultCommunicable Disease ControlFemaleFranceHospitalsHumansMaleMedical OncologyMiddle AgedPandemicsProspective StudiesCOVID-19lockdownpatients with cancerpost-traumatic stress disorder (PTSD)treatment adjustments

Identifiers

PMID34398970
PMCPMC8426939
OpenAlexW3194126546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.